Chart pattern: Double Bottom (weekly)
▲ Broken out
Broke on Oct 09, 2026 · measured target $28.10 (-11%). Details →
Nov 4, 6:55 AM ET
Option Care Health reported third quarter 2026 results with net revenue of $1,493.5 million, up 4.1%, and GAAP diluted earnings per share of $0.38, up 18.8%. The company withdrew its previously disclosed financial guidance and will not host an earnings call because of its pending acquisition by Clayton, Dubilier & Rice, LLC and McKesson Corporation.
- Net revenue of $1,493.5 million, up 4.1% year over year; GAAP net income of $57.4 million, up 10.8%
- GAAP diluted EPS of $0.38, up 18.8%; adjusted diluted EPS of $0.49, up 8.9%
- Financial guidance withdrawn and no earnings conference call, given the pending merger agreement with Clayton, Dubilier & Rice, LLC and McKesson Corporation
Read the filing on SEC.gov ↗
Oct 6, 8:22 AM ET
Option Care Health entered into a merger agreement on October 5, 2026, under which an investor group of CD&R affiliates and McKesson Corporation would acquire the company for $32.05 per share in cash, a total enterprise value of approximately $5.8 billion. The price represents a premium of approximately 37% to the October 5, 2026 closing share price, and the company's board unanimously recommended the deal to stockholders. Shareholders would receive cash and the stock would no longer be publicly listed on Nasdaq once the deal closes, which is expected in the first half of 2027, subject to stockholder and regulatory approvals.
- Cash consideration of $32.05 per share, a premium of approximately 37% to the October 5, 2026 closing price
- Total enterprise value of approximately $5.8 billion; McKesson to invest approximately $1.4 billion for an approximately 49% minority interest
- Closing expected in the first half of calendar year 2027, subject to stockholder approval and regulatory approvals
- Company is withdrawing its previously disclosed 2026 guidance and will not host a call for its third quarter 2026 results, which it expects to release on November 4, 2026
Read the filing on SEC.gov ↗
Jul 29, 6:56 AM ET
Option Care Health reported second quarter 2026 results, with net revenue of $1.44 billion, up 1.9% from a year earlier, and GAAP net income of $53.9 million, up 6.7%. The company also issued updated full-year 2026 guidance, including adjusted diluted EPS of $1.85 to $1.92, and repurchased $150 million of its shares during the quarter.
- Q2 2026 net revenue of $1,442 million, up 1.9% year over year
- GAAP diluted EPS of $0.35, up 12.9%; adjusted diluted EPS of $0.45, up 9.8%
- Full-year 2026 guidance: net revenue $5.675 billion to $5.775 billion; adjusted EBITDA $480 million to $495 million
- Repurchased $150 million of outstanding shares in the quarter
Read the filing on SEC.gov ↗
May 5, 4:01 PM ET
Option Care Health said Chief Growth Officer Christopher L. Grashoff will leave his role effective May 8, 2026. He will receive separation benefits under the company's Amended and Restated Executive Severance Plan, conditioned on a general release of claims and continued compliance with restrictive covenants. The filing does not name a successor or describe any financial impact.
- Christopher L. Grashoff departs as Chief Growth Officer effective May 8, 2026
- Separation benefits are conditioned on a general release of claims and continued compliance with restrictive covenants
- Benefits follow the Amended and Restated Executive Severance Plan; no dollar amounts are disclosed
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.